Tendons and ligaments are among the most difficult tissues to heal — they are hypovascular, hypocellular, and have very low metabolic activity, resulting in slow and often incomplete repair that leaves behind mechanically inferior scar tissue. Peptide research dramatically accelerates tendon and ligament healing by promoting angiogenesis, fibroblast recruitment, and organized collagen deposition.
1. BPC-157 — Tendon / Ligament Healing Foundation
BPC-157 has the most robust evidence for tendon and ligament healing of any peptide studied. It dramatically accelerates the healing of ruptured tendons and ligaments in animal models — partly by upregulating growth hormone receptors on tendon fibroblasts, stimulating VEGF-driven angiogenesis to the avascular tendon core, and reducing the inflammatory environment that inhibits healing.
Dosing Protocol: 250–500 mcg SubQ daily, injected near the injured tendon/ligament. Can be combined with intralesional injection in clinical settings. Cycle: 6–12 weeks depending on severity.
2. TB-500 — Fibroblast Migration / Anti-Adhesion
TB-500 promotes the migration of tenocytes (tendon fibroblasts) into the injury zone via actin regulation and reduces the formation of inflammatory adhesions that cause scar-related stiffness and re-injury. It also reduces the fibrotic overgrowth that produces mechanically inferior tendon repair.
Dosing Protocol: 2 mg SubQ twice weekly for 4–6 weeks, then 2 mg weekly. Essential combination with BPC-157 for serious tendon injuries.
3. IGF-1 LR3 — Tenocyte Proliferation
IGF-1 is a potent mitogen for tendon fibroblasts and promotes collagen type I synthesis — the structural collagen of tendons and ligaments. IGF-1 LR3 provides sustained anabolic signaling that drives rapid tenocyte proliferation and collagen production during the critical proliferative healing phase.
Dosing Protocol: 20–40 mcg SubQ daily, near injury site. Cycle: 4 weeks on, 4 weeks off.
4. GHK-Cu — Collagen Cross-Linking / Tensile Strength
The tensile strength of healed tendon depends on organized collagen cross-linking. GHK-Cu activates lysyl oxidase enzymes responsible for collagen cross-link formation, ensuring the newly synthesized collagen develops the mechanical strength needed to withstand loading. Without adequate cross-linking, healed tendon remains weak and prone to re-injury.
Dosing Protocol: 1–2 mg SubQ daily. Topical application directly over the tendon as adjunct. Cycle: 8 weeks.
BPC-157 and TB-500 create the vascular and cellular conditions for tendon repair — BPC-157 driving angiogenesis and receptor sensitivity while TB-500 recruits tenocytes to the repair zone. IGF-1 LR3 triggers rapid proliferation of those tenocytes to produce new collagen. GHK-Cu ensures that collagen is properly cross-linked into the mechanically strong matrix that defines a truly healed tendon.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).